Sennoside 8.6mg
NDC 70692-112
Product Information
Sennoside 8.6mg is a OTC MONOGRAPH NOT FINAL-approved product labeled by Strive Pharmaceuticals Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a gray product. This product entry covers the primary NDC 70692-112 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
S3
Code Structure Chart
Product Details
What is NDC 70692-112?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SENNOSIDES A AND B (UNII: 1B5FPI42EN)
- SENNOSIDES A AND B (UNII: 1B5FPI42EN) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 312935 - sennosides 8.6 MG Oral Tablet
- RxCUI: 312935 - sennosides, USP 8.6 MG Oral Tablet
- RxCUI: 312935 - sennosides A and B 8.6 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.